|
|
Résultats pour
brevets
1.
|
CRM197 protein expression method
| Numéro d'application |
17638822 |
| Numéro de brevet |
12492228 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2019-10-02 |
| Date de la première publication |
2022-09-08 |
| Date d'octroi |
2025-12-09 |
| Propriétaire |
- GENOFOCUS CO., LTD. (République de Corée)
- EUBIOLOGICS.CO., LTD. (République de Corée)
|
| Inventeur(s) |
- Kim, Jeong Hyun
- Kim, Hyun-Do
- Park, Eun-Hye
- Kang, Jung Hyun
- Pan, Jae Gu
- Kim, Eui Joong
- Lee, Chankyu
- Park, Minchul
|
Abrégé
Escherichia coli of which a redox potential is not adjusted, and a CRM197 protein having high periplasmic secretion efficiency may be produced even without shifting the pH of a culture medium in order to increase secretion into the periplasm, and thus the present invention is very useful in CRM197 protein production.
Classes IPC ?
- C12P 21/02 - Préparation de peptides ou de protéines comportant une séquence connue de plusieurs amino-acides, p. ex. glutathion
- A61K 39/05 - CorynebacteriumPropionibacterium
- C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
- C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
|
2.
|
CRM197 PROTEIN EXPRESSION METHOD
| Numéro d'application |
KR2019012899 |
| Numéro de publication |
2021/045292 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2019-10-02 |
| Date de publication |
2021-03-11 |
| Propriétaire |
- GENOFOCUS CO., LTD. (République de Corée)
- EUBIOLOGICS.CO.,LTD (République de Corée)
|
| Inventeur(s) |
- Kim, Jeong Hyun
- Kim, Hyun-Do
- Park, Eun-Hye
- Kang, Jung Hyun
- Pan, Jae Gu
- Kim, Eui Joong
- Lee, Chankyu
- Park, Minchul
|
Abrégé
The present invention relates to a signal sequence for expressing a CRM197 protein in Escherichia coli and secreting same into the periplasm, and a use thereof, and more specifically, to: a signal sequence for expressing a CRM197 protein; a nucleic acid for coding the signal sequence; a nucleic acid construct or expression vector comprising the nucleic acid and a CRM197 protein gene; a recombinant microorganism having the nucleic acid construct or expression vector introduced therein; and a CRM197 protein production method comprising a step for culturing the recombinant microorganism. According to the present invention, a CRM197 protein having the same physicochemical/immunologic properties as the protein isolated from the parent bacteria may be expressed even in regular Escherichia coli of which a redox potential is not adjusted, and a CRM197 protein having high periplasmic secretion efficiency may be produced even without shifting the pH of a culture medium in order to increase secretion into the periplasm, and thus the present invention is very useful in CRM197 protein production.
Classes IPC ?
- C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
- C07K 14/00 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
- C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
|
3.
|
CRM197 PROTEIN EXPRESSION METHOD
| Numéro de document |
03149784 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2019-10-02 |
| Date de disponibilité au public |
2021-03-11 |
| Date d'octroi |
2025-05-13 |
| Propriétaire |
- GENOFOCUS CO., LTD. (République de Corée)
- EUBIOLOGICS.CO.,LTD (République de Corée)
|
| Inventeur(s) |
- Kim, Jeong Hyun
- Kim, Hyun-Do
- Park, Eun-Hye
- Kang, Jung Hyun
- Pan, Jae Gu
- Kim, Eui Joong
- Lee, Chankyu
- Park, Minchul
|
Abrégé
The present invention relates to a signal sequence for expressing a CRM197 protein in Escherichia coli and secreting same into the periplasm, and a use thereof, and more specifically, to: a signal sequence for expressing a CRM197 protein; a nucleic acid for coding the signal sequence; a nucleic acid construct or expression vector comprising the nucleic acid and a CRM197 protein gene; a recombinant microorganism having the nucleic acid construct or expression vector introduced therein; and a CRM197 protein production method comprising a step for culturing the recombinant microorganism. According to the present invention, a CRM197 protein having the same physicochemical/immunologic properties as the protein isolated from the parent bacteria may be expressed even in regular Escherichia coli of which a redox potential is not adjusted, and a CRM197 protein having high periplasmic secretion efficiency may be produced even without shifting the pH of a culture medium in order to increase secretion into the periplasm, and thus the present invention is very useful in CRM197 protein production.
Classes IPC ?
- C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
- C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
|
4.
|
CORYNEBACTERIUM STRAIN EXPRESSING HIGH CONCENTRATION OF CRM197
| Numéro d'application |
KR2019008646 |
| Numéro de publication |
2020/017832 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2019-07-12 |
| Date de publication |
2020-01-23 |
| Propriétaire |
EUBIOLOGICS.CO.,LTD (République de Corée)
|
| Inventeur(s) |
- Lee, Chan Kyu
- Yoon, Hye Seon
- Kim, Hee Youn
- Lee, In Hwan
- Park, Min Chul
|
Abrégé
Corynebacteriumdiphtheriaediphtheriae EB01 (KCTC13549BP) which expresses a high concentration of CRM197, according to the present invention, is a double lysogenic strain with which the expression of CRM197 is 1.5 times to 3 times greater than when a single lysogenic strain is used, and thus the time and cost required for production can be reduced. Since the Corynebacterium strain can express high concentrations of CRM197 without being affected by the concentration of Fe 2+, a step for removing Fe 2+is unnecessary during the preparation of a culture medium, and bacterial growth can be improved under conditions of high Fe 2+ concentration without influencing the expression of CRM197, and as a result, the productivity of CRM197 can be improved. Ultimately, this enables production of a high yield of CRM197 through simpler processes, such that manufacturing costs are reduced, and thus it is possible to develop an economical conjugate vaccine production process.
Classes IPC ?
- C12N 15/77 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour CorynebacteriumVecteurs ou systèmes d'expression spécialement adaptés aux hôtes procaryotes autres que E. coli, p. ex. Lactobacillus, Micromonospora pour Brevibacterium
- C12N 15/01 - Préparation de mutants sans introduction de matériel génétique étrangerProcédés de criblage à cet effet
- C12N 1/20 - BactériesLeurs milieux de culture
- C07K 14/34 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Corynebacterium (G)
- C12R 1/16 - Corynebacterium diphtheriae
|
|